SCHEMBL6787347

SCHEMBL6787347

CCOC(=O)C(Br)c1ccc(OC)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.49
ALDH1A1 P00352 5/20 0.46
KMT2A Q03164 4/20 0.46
HDAC3 O15379 2/20 0.45
HDAC4 P56524 2/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC7 Q8WUI4 2/20 0.45
HDAC2 Q92769 2/20 0.45
HDAC10 Q969S8 2/20 0.45
HDAC11 Q96DB2 2/20 0.45
HDAC8 Q9BY41 2/20 0.45
HDAC6 Q9UBN7 2/20 0.45
HDAC9 Q9UKV0 2/20 0.45
HDAC5 Q9UQL6 2/20 0.45
GLA P06280 1/20 0.45
HPGD P15428 2/20 0.44
GAA P10253 2/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 2/20 0.43
GSK3B P49841 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8849171 0.89 MMP8 (0.43) ALDH1A1KMT2ALMNAMEN1TSHR
SCHEMBL11781051 0.86 AKR1C3 (0.57) ALDH1A1HPGDKDM4ELMNAL3MBTL1
SCHEMBL6905840 0.84 MEN1 (0.46) ALDH1A1KMT2AGAALMNAMEN1
SCHEMBL378101 0.84 KMT2A (0.49) ALDH1A1KMT2AMEN1NPC1HTT
SCHEMBL11479523 0.83 ESR1 (0.45) ALDH1A1KMT2AKDM4ELMNAPOLB
SCHEMBL1043694 0.82 ALOX15 (0.51) ALOX15ALDH1A1KMT2AHDAC3HDAC4
SCHEMBL324361 0.82 KMT2A (0.47) ALDH1A1KMT2AHPGDGAAKDM4E
SCHEMBL12920265 0.82 ESR1 (0.52) ALOX15ALDH1A1KMT2AGAAKDM4E
SCHEMBL9869760 0.82 KLK7 (0.52) ALOX15ALDH1A1KMT2AHDAC3HDAC4
SCHEMBL9393808 0.82 ALOX15 (0.49) ALOX15ALDH1A1KMT2AHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720034-A1 NOVEL COMPOUNDS TO TREAT VIRAL INFECTIONS Zydus Lifesciences Limited (IN) 2026-04-08 EP disclosed
WO-2024252254-A1 NOVEL COMPOUNDS TO TREAT VIRAL INFECTIONS ZYDUS LIFESCIENCES LIMITED (IN) 2024-12-12 WO disclosed
US-7642358-B2 Substituted phenylacetic acids METABOLEX, INC. (US) 2010-01-05 US disclosed
US-7642358-B2 Substituted phenylacetic acids METABOLEX, INC. (US) 2010-01-05 US disclosed
US-6825354-B2 OSTEOPOROSIS; RHEUMATIC DISEASES WYETH HOLDINGS CORPORATION 2004-11-30 US disclosed
US-6806267-B1 ANTITUMOUR AGENTS; OVERCOMING CHRONIC MYELOID LEUKEMIA ASSOCIATED DRUG RESISTANCE; SUCH AS 4-ACETOXY-5-PHENYL-NAPHTO(2,3-B)PYRROLO(1,2-D)(1,4)OXAZEPINE THE UNIVERSITA'DI SIENA (IT) 2004-10-19 US disclosed
EP-1255758-A1 APOPTOSIS-INDUCING COMPOUNDS THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2002-11-13 EP disclosed
WO-2001058904-A1 APOPTOSIS-INDUCING COMPOUNDS THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2001-08-16 WO disclosed
US-4748272-A Phenoxyphenylacetates for use as potential modulators of arichidonic acid pathways RORER PHARMACEUTICAL CORP. (US) 1988-05-31 US disclosed